Bryan Roth and Gary Johnson Awarded NIH Grants From the NIH Illuminating the Druggable Genome Initiative
Drs. Bryan Roth and Gary Johnson receive 2 of 9 grants awarded by the NIH Illuminating the Druggable Genome Initiative which is supporting research to study 4 of the most commonly drug-targeted protein families
Zefeng Wang's paper published in Cancer Cell this week shows that the splicing factor RBM4 suppresses proliferation and migration of various cancer cells by specifically controlling cancer-related splicing.
Michael Miley, PhD, and Ashutosh Tripathy, PhD, are the new co-directors for the UNC Center for Structural Biology (CSB). CSB has also launched a brand new website.
Dr. Terry Kenakin to Receive the 2014 Gaddum Memorial Award from the British Pharmacological Society.
Press release by Mark Derewicz for UNC Hahn Lab paper published online in Nature Chemical Biology March 9, 2014.
New targeted therapies for pain, Parkinson's disease, and depression carry the promise of greater benefit for patients without serious side effects.
In a paper published in Nature Neuroscience on November 10, Juan Song discovers how baby neurons stay alive, a key finding for understanding neurodegenerative diseases, such as Alzheimer’s.
In the first application of this approach, the UNC researchers showed how a protein called Src kinase influences the way cells extend and move, a previously unknown role that is consistent with the protein’s ties to tumor progression and metastasis.
Bryan Roth and Collaborators Have Back to Back Papers Published in Science on Discovery of Structure of Serotonin Receptors
The Roth Lab in collaboration with Ray Stevens' Lab at Scripps Research Institute had 2 papers published on Science's advanced online publishing website, Science Express, March 21, 2013. The papers describe the structure of serotonin receptors and how the structure of the receptors shapes drug effects.